Loading...
Australian Pharmaceutical Industries drops its stake in Sigma Healthcare.
Australan Pharmaceutical Industries has just confirmed the sale of its shares in Sigma Healthcare Limited, acquired last year as part of the now aborted proposed merger between the companies.
The sale of 137,264,592 Sigma shares means API now no holds no shares in Sigma. API Chairman Mark Smith said "the strategic and commercial fundamentals that made the merger a compelling proposigion for both sets of shareholders have significantly diminished".
He said selling the Sigma shares would allow API to futher accelerate its focus on its existing portfolio.
More details in tomorrow's issue of Pharmacy Daily.
This Pharmacy Daily breaking news is brought to you by JPH Group
To ensure you continue to receive email from Pharmacy Daily reliably please add info@pharmacydaily.com.au to your 'Safe Senders' list and set images to always display.
To forward this email to a friend click here. To receive your own copy of Pharmacy Daily sign up here.
To modify subscription details click here. To unsubscribe click here.
The Therapeutic Goods Advertising Code 2015 requires strict compliance. View the code here.
Pharmacy Daily - a division of Business Publishing Group
PO Box 1010 Epping NSW Australia 1710
Level 2, Suite 1 64 Talavera Rd Macquarie Park NSW 2113
Loading...
Loading...
